Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors: a safety meta-analysis of randomised controlled trials and a retrospective study of the WHO pharmacovigilance database
Published Online: 2021-02-?
Journal: The Lancet Haematology•Publisher: Elsevier BV
Authors: Alexandra Leary•Antonio González-Martín•Basile Chrétien•Charles Dolladille•Eileen Mary O'Reilly•Isabelle Ray-Coquard•Joachim Alexandre•Kathleen Moore•Laurent Poulain•Pierre-Marie Morice
